MedTrace Logo

Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials

NCT00451139 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-03-23

No results posted yet for this study

Summary

The purpose of the study is to evaluate the potential side-effects of artemether / lumefantrine and other antimalarials on the auditory function.

Conditions

Interventions

DRUG

artemether/lumefantrine

DRUG

quinine

DRUG

atovaquone/proguanil

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Jimma University

    lead OTHER

Principal Investigators

  • Nebreed Fesseaha, MD, Dean · Facuty of Medical Sciences Jimma University

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00451139 on ClinicalTrials.gov